- Home
- Products
Nextstellis (Drospirenone and Estetrol)
Nextstellis (Drospirenone and Estetrol)
- Medicine Name: Nextstellis
- Generic Name: Drospirenone and Estetrol
- Dosage Form & Strength: 28 Tablets – 3 mg / 14.2 mg
- Manufactured By: Mayne Pharma US
Nextstellis is the first and only FDA-approved oral contraceptive that combines drospirenone (a progestin) with estetrol (a plant-derived estrogen) to prevent pregnancy in women of reproductive age. Estetrol (E4) is a unique natural estrogen with tissue-selective activity, supporting uterine and bone health while minimizing liver and breast impact.
Important Note: Efficacy may be reduced in individuals with BMI ≥ 30, and it is not recommended for use in women with BMI ≥ 35 due to limited data.
Dosage:
- One active pink tablet daily for 24 days, followed by
- One inactive white tablet daily for 4 days, for a total 28-day cycle
- Take at the same time each day, with or without food
Missed Dose Protocol:
If vomiting or diarrhea occurs within 3–4 hours of ingestion, or if two or more active tablets are missed, follow backup contraceptive recommendations and resume the regular schedule.
Thrombotic Risk: Avoid in women with history or high risk of venous or arterial thrombotic disorders.
Migraine with Aura: Contraindicated in those with migraine with aura due to increased risk of stroke.
Hypertension: Avoid in uncontrolled hypertension; monitor BP in all users and discontinue if necessary.
Hormone-Sensitive Cancers: Not advised in women with current or past hormonally sensitive malignancies.
Liver Concerns: Avoid in patients with acute hepatitis or decompensated cirrhosis. Monitor liver enzymes if elevated.
Irregular Bleeding: Common during the first 3–4 months of use. Persistent or post-stabilization bleeding requires evaluation.
To import Nextstellis tablets to India, you must provide the following:
- Valid prescription from a licensed physician
- Diagnostic reports supporting the condition
- Government-issued ID proof
Availability:
Global Rare Meds facilitates import and delivery of Nextstellis 3 mg / 14.2 mg tablets to all major cities in India including Mumbai, Delhi, Bangalore, Pune, Hyderabad, Chennai, Ahmedabad, Kolkata, and more.
📧 info@globalraremeds.com
📞 +91-99675 15602 (Call/WhatsApp)
Global Rare Meds sources Nextstellis from certified suppliers in the US, Canada, and Europe. Through our fulfillment center in Ambernath, Thane District, we ensure:
- Safe & compliant import
- Verified prescription fulfillment
- Fast delivery across India
- 100% transparency in pricing and sourcing
Q: What is Nextstellis used for?
A: Nextstellis is a daily oral contraceptive used to prevent pregnancy in women of reproductive age.
Q: What is the generic name of Nextstellis®?
A: Drospirenone and Estetrol
Q: Who manufactures Nextstellis®?
A: Mayne Pharma US
Q: Is Nextstellis® approved by the FDA?
A: Yes. FDA approval was granted on April 15, 2021.
Q: What is the dosing regimen?
A: 24 pink active tablets (3 mg / 14.2 mg) + 4 white inert tablets, taken consecutively over 28 days.
Q: What are the common side effects of Nextstellis?
A:
- Mood changes
- Headache
- Irregular bleeding
- Acne
- Breast tenderness
- Decreased libido
- Weight gain
Q: How should Nextstellis be stored?
A: Store at 20–25°C, with permissible excursions between 15–30°C. Keep in original blister packaging.
Q: Is it safe to order Nextstellis online in India?
A: Yes, Global Rare Meds legally imports Nextstellis tablets under Named Patient Supply provisions, with verified sourcing and express delivery.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
